CJC-1295 (no DAC) | Ipamorelin
GHRH + GH Secretagogue Blend
Blend Components:
CJC-1295 (no DAC)
CAS: 863288-34-0
Formula: C152H252N44O42
M.W.: 3367.8956 g/mol
Ipamorelin
CAS: 170851-70-4
Formula: C38H49N9O5
M.W.: 711.8531 g/mol
Purity: 99%+ HPLC Verified
Ref No.: CJI-0005VI
For Research Use Only (RUO)
Not for human or veterinary use.
CJC-1295 (no DAC) | Ipamorelin
Category
GH / Neuro / Misc Research
Form Factor
Lyophilized Powder
Blend Components
CJC-1295 (no DAC)
5 mg
CAS: 863288-34-0
Ipamorelin
5 mg
CAS: 170851-70-4
CJC-1295 (no DAC)
CAS
863288-34-0
Formula
C152H252N44O42
Molar Mass
3367.8956 g/mol
Ipamorelin
CAS
170851-70-4
Formula
C38H49N9O5
Molar Mass
711.8531 g/mol
In stock, ready to ship
Ships same day before 12pm PST
Products are shipped in lyophilized powder form.
This synergistic blend combines CJC-1295 (no DAC), a GHRH analog, with Ipamorelin, a selective GH secretagogue. By targeting two distinct receptor systems simultaneously, it produces amplified, pulsatile growth hormone release exceeding what either peptide achieves independently.
Description
This synergistic blend combines CJC-1295 (no DAC), a GHRH analog, with Ipamorelin, a selective GH secretagogue. By targeting two distinct receptor systems simultaneously, it produces amplified, pulsatile growth hormone release exceeding what either peptide achieves independently.Chemical Information
Purity
99%+ HPLC Verified
Form Factor
Lyophilized Powder
Synonyms
Blend Components
CJC-1295 (no DAC)
5 mg
CAS: 863288-34-0
Ipamorelin
5 mg
CAS: 170851-70-4
CJC-1295 (no DAC)
CAS
863288-34-0
Formula
C152H252N44O42
Molar Mass
3367.8956 g/mol
Ipamorelin
CAS
170851-70-4
Formula
C38H49N9O5
Molar Mass
711.8531 g/mol
Research Applications
- Endocrinology: This blend is studied for the synergistic effects of combining a GHRH analog (CJC-1295) with a selective GH secretagogue (Ipamorelin). Research demonstrates that co-administration produces amplified GH pulses exceeding the sum of individual peptide effects, suggesting receptor-level synergism between GHRH and ghrelin pathway activation. Studies examine the optimal timing, ratios, and dosing strategies for maximum synergy.
- Body Composition: The CJC-1295/Ipamorelin blend is actively studied for body composition optimization. Research examines its effects on lean mass accretion, visceral and subcutaneous fat reduction, and metabolic rate enhancement. The combination's favorable side effect profile — minimal cortisol and prolactin elevation — makes it suitable for long-term body composition research protocols.
- Pharmacology: This blend serves as a model for receptor-level synergism studies in GH secretagogue pharmacology. Research examines how simultaneous GHRH receptor and ghrelin receptor activation produces supra-additive GH release, including potential mechanisms involving intracellular calcium signaling, cAMP amplification, and somatotroph cell membrane depolarization.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for CJC-1295 (no DAC) | Ipamorelin — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
You May Also Like
-
$85 – $139.99
Tesamorelin
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$59.99 – $79.99
BPC-157
Regenerative ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$79.99
MOTS-c
GLP / Metabolic ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$124.99
Semax (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details
For Enhanced GHRH signaling Research
For Tissue repair during GH protocols Research
For Metabolic & mitochondrial support Research
Popular Product
Description
This synergistic blend combines CJC-1295 (no DAC), a GHRH analog, with Ipamorelin, a selective GH secretagogue. By targeting two distinct receptor systems simultaneously, it produces amplified, pulsatile growth hormone release exceeding what either peptide achieves independently.Chemical Information
Purity
99%+ HPLC Verified
Form Factor
Lyophilized Powder
Synonyms
Blend Components
CJC-1295 (no DAC)
5 mg
CAS: 863288-34-0
Ipamorelin
5 mg
CAS: 170851-70-4
CJC-1295 (no DAC)
CAS
863288-34-0
Formula
C152H252N44O42
Molar Mass
3367.8956 g/mol
Ipamorelin
CAS
170851-70-4
Formula
C38H49N9O5
Molar Mass
711.8531 g/mol
Research Applications
- Endocrinology: This blend is studied for the synergistic effects of combining a GHRH analog (CJC-1295) with a selective GH secretagogue (Ipamorelin). Research demonstrates that co-administration produces amplified GH pulses exceeding the sum of individual peptide effects, suggesting receptor-level synergism between GHRH and ghrelin pathway activation. Studies examine the optimal timing, ratios, and dosing strategies for maximum synergy.
- Body Composition: The CJC-1295/Ipamorelin blend is actively studied for body composition optimization. Research examines its effects on lean mass accretion, visceral and subcutaneous fat reduction, and metabolic rate enhancement. The combination's favorable side effect profile — minimal cortisol and prolactin elevation — makes it suitable for long-term body composition research protocols.
- Pharmacology: This blend serves as a model for receptor-level synergism studies in GH secretagogue pharmacology. Research examines how simultaneous GHRH receptor and ghrelin receptor activation produces supra-additive GH release, including potential mechanisms involving intracellular calcium signaling, cAMP amplification, and somatotroph cell membrane depolarization.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for CJC-1295 (no DAC) | Ipamorelin — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
